Cardiology

Daily intake of avocado and mango could improve cardiovascular health in adults with prediabetes, a 2026 study has found.

By mapping the interaction between TMAO and fibrinogen, the researchers were able to identify specific binding sites and structural changes that increase clot stability.

Fetal cardiac imaging at 34–38 weeks identified newborns with transposition of the great arteries at high risk of severe hypoxia that would need urgent postnatal intervention.

Analysis revealed that a higher abundance of Eubacterium xylanophilum group spp. and Akkermansia muciniphila was associated with a lower risk of MACE+, whereas Ruminococcus gnavus group spp. was linked to higher MACE risk.

Animals receiving RIC maintained significantly better cardiac function. The intervention preserved left ventricular ejection fraction and partially prevented early structural changes in the heart.

Participants with depression alone had the highest risk (HR: 1.60; 95% CI: 1.36–1.89), followed by those with both depression and VI (HR 1.56; 95% CI: 1.40–1.73).

NHS England London has launched a five-year, city-wide programme to improve heart health in the capital.

Over an approximate 4-year period, increasing sleep apnoea severity showed a clear dose–response relationship with higher PWV, independent of age, sex, and body mass index.

Mimio reduced total cholesterol, LDL cholesterol, LDL particle number, oxidised LDL, non-HDL cholesterol, and fasting glucose.

The team demonstrated that CCN5 effectively inhibited doxorubicin-induced cardiac cellular senescence in both cardiac myoblasts and fibroblasts.

Deep learning models, particularly a Convolutional Neural Network, demonstrated superior performance, achieving an accuracy of 99.89% in predicting cardiac arrest.

Five key determinants of cardiac tamponade were highlighted: operator experience, D-dimer level, total heparin dose, AF type, and left atrial diameter.

AI-enhanced stethoscope screening improves early detection of valvular heart disease, outperforming general practitioners in this study.

Quantitative coronary CT plaque measures independently predicted major adverse cardiovascular events, improving risk stratification in patients.

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

Performance on the one-minute sit-to-stand test was a strong predictor of prognosis. Each additional repetition was associated with a lower risk of adverse outcomes (hazard ratio: 0.94; 95% CI: 0.90–0.98; p

The newly developed AI tool, known as ONCO-ACS, was designed specifically to predict six-month mortality, major bleeding, and ischaemic events in patients with cancer and acute coronary syndrome.

The study reported that 40.1% of patients with AF had either large non-cortical and cortical infarcts or small non-cortical infarcts, compared with 24.0% of patients without AF.

Those exposed to early-life sugar rationing had an approximately 14% lower risk of developing heart failure and were diagnosed an average of 2.6 years later than individuals who were unexposed.

Those with ASCVD were more likely to experience somatic symptoms (OR 1.138; 95% CI 1.069–1.212), anxiety and insomnia (OR 1.113; 95% CI 1.043–1.188), and severe depression (OR 1.173; 95% CI 1.084–1.269).

MPO concentrations in selectively drained pericardial fluid were 25-fold higher than mixed drainage samples and 1,648-fold higher than serum levels (both p

Overexpression of hsa-miR-339-5p suppressed NLRC5, activated the PI3K/Akt signalling pathway, and significantly increased type 1 collagen and α-smooth muscle actin expression, indicating enhanced fibrotic remodelling.

AI echocardiography using multimodal right ventricular assessment predicted mortality in pulmonary hypertension.

Volumetric non-invasive cardiac mapping reduced geodesic localisation error by 59.3% compared with surface-only approaches, demonstrating substantially improved accuracy in identifying arrhythmia origins.

The results showed that patients receiving the STDP experienced significant reductions in CTFC in both the left anterior descending artery and left circumflex artery (both p

After adjusting for established cardiovascular risk factors, each standard deviation increase in LOY was associated with a 14% higher risk of myocardial infarction.

Very high lipoprotein(a) predicts decades of cardiovascular risk, guiding screening, personalised prevention, and earlier clinical intervention for women.

Higher cardiovascular risk may signal increased likelihood of eye disease. Find out more about protecting long-term eye health.

The results suggest that treatment once weekly with semaglutide could reduce the frequency and duration of hospital admissions for patients at high cardiovascular risk…

An increased polygenic score for HCM was associated with an 1.1% increase in left ventricular ejection fraction…

New research links contraceptive use, mental health and differing heart risk profiles in women.

New research shows combining biomarkers and genetics may dramatically improve heart disease risk assessment and prevention strategies.

Find out more about early evidence supporting biomarker-guided cardioprotection in patients receiving anthracycline therapy.

A major study examines ten-year heart changes in marathon runners, revealing reassuring findings for recreational endurance athletes.

Early weight management in childhood significantly reduces the risk of developing coronary heart disease later in life.

New research shows a quick neck ultrasound may identify older men at increased risk of heart failure.

USA adults living with heart failure have more than doubled since 1988, with risk factors shifting from hypertension and cholesterol to obesity, diabetes, and kidney disease.

Find out how an AI screening model greatly increases transthyretin cardiac amyloidosis diagnoses across a major health system.

Find out how shifting demographics and modifiable risks are accelerating the global cardiovascular disease burden.

New research reveals that low intensity smoking still drives major cardiovascular risks. Find out what the data shows.

The study also identified a significant excess of ultrarare regulatory variants associated with cardiomyopathy, arrhythmia, and epilepsy genes.

A first-of-its-kind clinical trial finds that moderate coffee consumption may actually protect the heart, reducing AF recurrence risk.

Study finds placental malperfusion worsens outcomes in congenital heart disease, revealing vital genetic and developmental connections.

A landmark study reveals COVID-19 in children causes higher, longer-lasting heart risks than the vaccine itself.

Scientists develop a saliva-based heart failure test that promises faster, cheaper, and more accurate diagnosis.

Researchers find stem cells reduce heart failure risk after myocardial infarction, offering promising results for cardiac recovery.

A 25-year study reveals surprising links between dairy and coronary artery disease. Discover how whole-fat dairy may protect heart health.

New findings show that blood pressure treatment improves retinal vessel health and may prevent hypertension-related damage.

Groundbreaking research links reduced sugar intake in early life to lower adult heart disease risk, highlighting long-term cardiovascular benefits.

A major study links light at night to higher heart disease risk. Learn how reducing night-time light could safeguard cardiovascular health.

A groundbreaking GRACE 3.0 scoring system harnesses AI to enhance heart attack risk prediction and guide personalised treatment worldwide.

Researchers find atrial cardiomyopathy strongly linked with atrial fibrillation, stroke, and heart failure, suggesting new prevention strategies in heart health.

New genetic study links plasma proteins to blood pressure regulation and cardiovascular disease, offering potential targets for heart health therapies.

Research shows inflammation and cholesterol levels increase long-term stroke risk in healthy women.

New research compares diabetes drugs and their impact on heart health in type 2 diabetes.

Heated tobacco use rises as heart hospitalisations fall in Japan, revealing a compelling new tobacco cardiovascular risk trend.

Processed food level, not plant-based label, determines heart disease risk, according to new French longitudinal cohort research.

A first-of-its-kind trial reveals how hormone therapy affects Cardiac Troponin I levels in transgender adults.

A new clinical trial shows food subsidies are more effective than meal boxes in supporting a healthy blood pressure diet.

Childhood cardiometabolic health trends show better lipids and blood pressure but rising insulin. Keep reading for findings and implications.

Cardiotoxic treatments in survivors link to gene markers, with new research highlighting NFE2L2 as a predictive biomarker.

Coronary heart disease almost always follows common risk factors, highlighting the urgent need for earlier prevention and control.

Delayed diagnosis of blood clots directly increases mortality, highlighting urgent need for faster action in patient care.

Survey finds supplement labels mislead consumers into thinking products prevent disease, prompting calls to tighten regulatory standards.

Cocoa flavanol supplements reduce key inflammatory markers linked to ageing and heart disease. Keep reading to learn their clinical potential.

Invasive strategy helps relieve angina faster in chronic coronary disease, while conservative care prolongs persistent symptoms, study finds.

Undiagnosed heart condition affects up to one in six older Black men with heart failure, new research finds.

Occlusion procedure offers safer stroke prevention than anticoagulants for dialysis patients with kidney failure, new study finds.

Abelacimab reduces bleeding risk in atrial fibrillation patients, even with kidney disease, study finds.

Learn if post-heart attack H. pylori screening prevents gastrointestinal bleeding and who might benefit. Keep reading for insights.

Women remain underrepresented in heart trials, a global review finds, risking gaps in tailored cardiovascular care and outcomes.

Find out how app-based messaging supports diabetes management and reduces cardiovascular risks in adults with poor control. Keep reading.

AF screening with an ECG patch led to a modest increase in AF diagnosis at 2.5 years

Understand how chamber volume ratios on MRI predict cardiac risk, even when heart chambers fall within normal size limits.

The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy.

In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients.

The POTCAST trial shows raising plasma potassium to high-normal levels reduces ventricular arrhythmia risk, hospitalisations, and death in ICD patients.

DIGIT-HF shows digitoxin reduces death and hospitalisation in advanced heart failure, offering an additional option for high-risk patients on top of standard therapy.

A large study finds age strongly increases arrhythmia risk, while higher fitness levels protect against atrial ectopy in asymptomatic adults.

Automatic chest compression devices outperform manual methods for CPR in simulated zero gravity, with piston devices meeting guideline-recommended standards.

A major analysis finds Afro-American patients with hypertension face higher cardiovascular morbidity, while Asian patients carry a greater risk of stroke.

COVID-19 survivors, especially women, show signs of vascular ageing, highlighting new risks for long-term heart health.

Nonviral gene therapy to boost brown fat molecule reverses age-related heart dysfunction in animal studies.

Study finds no long-term cardiovascular benefit from aspirin in healthy older people, but highlights increased bleeding risk.

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Semaglutide improves cardiovascular risk factors but raises health care costs, finds large multicentre cohort study.

CPAP therapy lowers cardiovascular risks in high-risk obstructive sleep apnoea patients, new multi-trial study finds.

Discover the higher risk of heart failure with pregabalin versus gabapentin in older adults. Read the full study findings.

Early cardiac rehabilitation did not improve function or rehospitalisation in severe heart failure, but mobility gains were seen.

Adults later diagnosed with cardiovascular disease show declining activity years before onset, highlighting the importance of lifelong exercise.

Tirzepatide improves outcomes in heart failure with obesity, with greatest physical benefits seen in those with higher BMI.

US heart deaths have dropped since 1970, but deaths from heart failure and arrhythmias are on the rise.

Discover how LMNA gene variant type and position impact cardiomyopathy risk—keep reading for clinical implications and treatment guidance.

Delayed hypertension diagnosis increases cardiovascular risk and lowers treatment rates, underscoring the value of prompt clinical action.

Discover how bedtime antihypertensive dosing benefits blood pressure control. Keep reading for clinical insights and recommendations.

AI screening from a single echocardiographic clip accurately detects cardiac amyloidosis, surpassing traditional diagnostic methods.

MAARS uniquely integrates electronic health records, imaging reports, and contrast-enhanced cardiac MRI using a transformer-based neural network.

GLP-1 receptor agonists cut heart, stroke, and kidney risks in people with MGUS and diabetes, new study finds.

Find out how epinephrine administration routes impact survival in paediatric cardiac arrest—explore the latest evidence now.

AI now matches experts in echocardiogram interpretation, promising faster, more accessible heart diagnostics for all patients.

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.

Edoxaban and rivaroxaban show best balance of efficacy and safety in elderly patients with atrial fibrillation.

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks remain unchanged.

Loneliness increases heart disease risk by 15% in both US and South Korea, major study finds.

Beta-blocker interruption after heart attack raises blood pressure and heart rate, increasing risks especially in hypertensive patients.

Timing doesn’t matter! Study finds no added heart benefit from bedtime blood pressure meds.

Understand how the DASH diet significantly lowers the risk of colorectal cancer, supporting dietary changes for cancer prevention.

Discover how yoga may reduce blood pressure, but further investigation is needed to validate these results.

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.

A new study has revealed a potential link between live zoster vaccination and a reduced risk of cardiovascular disease.

New risk model predicts hyperkalaemia in CKD and diabetes, enabling tailored care and safer treatment decisions for patients.

Pregnancies with mechanical heart valves carry high risks, as a global registry reveals stark outcomes.

Rising systolic blood pressure variability increases risks of heart disease, kidney disease, and death.

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Clinical trial results reveal that etripamil cuts emergency department visits by 39% inpatients with paroxysmal supraventricular tachycardia.

Early GDMT goals, especially blood pressure control, reduce the risk of CV events in chronic coronary disease.

New study shows all ADHD medications, not just stimulants, affect cardiovascular parameters in children, adolescents, and adults.

Wearable ECG shirt monitors heart rate recovery, predicting cardiovascular risk with 86% accuracy in new study.

Research reveals that hypertensive pregnancy disorders double dilated cardiomyopathy risk; highlighting that vigilance is needed postpartum.

Genetic study with 796,722 participants reveals that remnant cholesterol drives PAD risk independently.